Get started
Photocure $PHO.OL stock trade above resistance, close at 5yr hghRecent news by OSL:PHO : Randomized phase 3 study in Denmark demonstrates significant advantage in Bladder Cancer for Hexvix/Cysview blue light cystoscopy over standard white light variant: photocure.com At Q3 2019 Photocure reported continued record growth in the US as well as upfront payments from Chinese partner Asieris: photocure.com Further improvements for US reimbursements for Cysview from january 2020: photocure.com Technical analysis: Technical indicators sliding into high momentum and near overbought values at this price level, so any entry should be done with clear considerations of short term risks.
OSL:PHO
by savepiginvest
Salmar [SALM] Still consolidatingSalmar - Which is a Norwegian salmon company, has been consolidating in a roughly 15% price range the last weeks. Personally have I caught all but one of the ranges, and now it's back at the bottom so I thought I'd share it with you all. Price has been going back and forth from NOK - NOK for a good while now, And considering the world-wide population growth, and the world-wide love for Norwegian salmon (wink wink) I don't see any reason why they should fare worse in the near future. Currently long @ looking to sell @ - unless some unforseen news arrive.
OSL:SALMLong
by DonBboy
3
XXL - Heaven or Hell - When To Buy and When to Sell - LONG soonAs you can see on the following chart OSL:XXL may soon finish an A,B,C,D,E correction from a blistering 110 FX_IDC:NOKEUR from A to E. In an A,B,C,D,E we often see the last leg E extended further than the first leg A. Even though XXL has been through a shit storm of bad news, new board members and massive sell offs, it does not take away the fact that this may be an A,B,C,D,E correction. In terms of when to buy I'd like to add that you should never try to catch a falling a knife. Having said that the risk/reward by looking at the pure TA aspect looks rewarding, soon. Before this downtrend for OSL:XXL we had several large sports/outdoor shops (G-max, G-sport, Intersport, XXL). Due to falling consumer interest both G-max and G-sport has vanished giving OSL:XXL and Intersport the majority of the market for themselves. As we can see OSL:XXL is moving inside a triangle or falling wedge. I'd says that the correct time to buy would be when we see the first breakout and it stays out (If that happens) I think the breakout will come a bit before the report on last Q for this year. Hopefully a lot of the Christmas gifts under the trees this year will be from XXL... Having all this said we can see on the MACD that the signal line is struggling to find its way but we can see some bullish divergence on the RSI side. I myself will monitor OSL:XXL closely the next weeks, watch for a breakout on the upside that stays out and probably start taking some long positions in December(ish) depending if this plays out or not. Happy trading!
OSL:XXL
by Stilster
Digging deep, might be cheap...OSL:NOM has been trading in a downwards channel for quite some time. To say that OSL:NOM is out of the woods would be a bold statement. BUT based on the pure TA aspect you can clearly see a bounce of the longtime trendline forming a triple bottom. So based on that purely, this is a nice entry. Also an A,B,C,D,E has been formed in the trading channel, uptrend to be seen after E but still, a halt on the top of the trading channel. This being said, if you zoom in, a potential bull flag has emerged which just might indicate a push towards and through the top of the channel. If this occurs, breakout and stay out we might see some decent gains. I'm aware of the 4-5-6 stock issues. But i'm only basing my entry on the TA aspect. Happy trading!
OSL:NOMLong
by Stilster
3
PCI Biotech $PCIB.OL testing breakout from yearlong downtrendPCI Biotech Holding OSL:PCIB stock has been consolidating in a trading range below last years 30 NOK shareprice rights issue of NOK 360 million. Positive market reaction to the latest quarterly report from the company, along with good coverage in magasines: www.tu.no (norwegian language) nordiclifescience.org (page 91-94) At the moment, the stock is testing a breakout from the old trading range, and longs will be keen to see further conference or scientific journal coverage of the ongoing clinical programs for the companys FimaCHEM and FimaVACC products, as well as partnering deals for its FimaNAC product.
OSL:PCIBLong
by savepiginvest